All In Biotech

Drug Trial Radar · NCT00540618

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

A Phase II Randomized, Placebo-Controlled, Double-Blind Study of MEDI-507, A Humanized Monoclonal Antibody That Binds to the CD2 Receptor, Administered by Subcutaneous Injection to Adults With Plaque Psoriasis.

Last checked: Nov 20, 2026Latest source record: Nov 28, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

420

Actual

Start

Sep 2001

Primary completion

Not stated

Study completion Jul 2003

Sponsor

Lead sponsor
MedImmune LLCAstraZeneca (AZN)
Sponsor type
Industry
First posted
Oct 8, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Single group
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare disease activity, as measured by PASI score, of three MEDI-507 dosing (injection)regimens vs. placebo.

Conditions

  • Plaque Psoriasis

Interventions

  • MEDI-507Drug

    Compare in a placebo controlled manner, the disease activity of three dosing regimens of MEDI-507 (Monoclonal Antibody)

  • PlaceboOther

  • MEDI-507Drug

    Monoclonal Antibody (5 mg for 12 weeks and 5 mg for 6 weeks)

  • MEDI-507Drug

    Administered 7 mg for 4 weeks by injection (Monoclonal Antibody)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Biological activity will be assessed primarily by the Psoriasis Activity and Severity Index (PASI)Time frame: Days 14, 28, 42, 56, 70, 91, 107, and 167

Locations

43 sites in 2 countries. Site status is shown where the registry gives one.

  • MDS Pharma Services (US) Inc.

    Phoenix, Arizona

  • Bressinck-Parker-Dinehart-Sangster Dermatology, PA

    Little Rock, Arkansas

  • Associates in Research, Inc.

    Fresno, California

  • nTouch Research Corporation

    San Diego, California

  • Solano Clinical Research

    Vallejo, California

  • Dermatology Specialists, Inc.

    Vista, California

  • Colorado Medical Research Center, Inc.

    Denver, Colorado

  • Cherry Creek Dermatology

    Denver, Colorado

  • The Savin Center, PC

    New Haven, Connecticut

  • North Florida Dermatology Associates, PA

    Jacksonville, Florida

  • ICSL-Clinical Studies

    Sarasota, Florida

  • Comprehensive Research Institute

    Tampa, Florida

  • Atlanta Dermatology, Vein & Research Center, LLC

    Alpharetta, Georgia

  • Northwestern University Medical School

    Chicago, Illinois

  • Research Solutions, LLC

    Evansville, Indiana

  • The South Bend Clinic

    South Bend, Indiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • FutureCare Studies

    Springfield, Massachusetts

  • Washington University School of Medicine

    St Louis, Missouri

  • University of Medicine & Dentistry of New Jersey Robert Wood Johnson Medical School and Clinical Research Center

    New Brunswick, New Jersey

  • Probe Inc.

    Riverside Park, New Jersey

  • Associates in Dermatology Research

    Rutherford, New Jersey

  • Sadick Research Group

    New York, New York

  • Mount Sinai School of Medicine

    New York, New York

  • Wake Forest University School of Medicine

    Winston-Salem, North Carolina

  • University Dermatology Consultants, Inc.

    Cincinnatti, Ohio

  • Oregon Medical Research Center, PC

    Portland, Oregon

  • Northeast Clinical Research Center

    Allentown, Pennsylvania

  • Paddington Testing Company

    Philadelphia, Pennsylvania

  • Radiant Research

    Philadelphia, Pennsylvania

  • Clinicalm Partners-LLC

    Johnston, Rhode Island

  • Harmony Clinical Research, Inc.

    Johnson City, Tennessee

  • Dermatology Consultants, PC

    Nashville, Tennessee

  • Veteran's Administration Medical Center

    Nashville, Tennessee

  • Breco Research, Ltd.

    Houston, Texas

  • Dermatology Clinical Research Center of San Antonio

    San Antonio, Texas

  • The Dermatology Centre

    Calgary, Alberta, Canada

  • NewLab Clinical Research

    St. John's, Newfoundland and Labrador, Canada

  • Queen Elizabeth II Health Sciences Center

    Halifax, Nova Scotia, Canada

  • Probity Medical Research

    Waterloo, Ontario, Canada

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.